Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

被引：72

作者：

Lemieux, B ^{[1
]}

Tartas, S ^{[1
]}

Traulle, C ^{[1
]}

Espinouse, D ^{[1
]}

Thieblemont, C ^{[1
]}

Bouafia, F ^{[1
]}

Alhusein, Q ^{[1
]}

Antal, D ^{[1
]}

Salles, G ^{[1
]}

Coiffier, B ^{[1
]}

机构：

[1] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Haematol, F-69495 Pierre Benite, France

来源：

BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 09期

关键词：

non-Hodgkin's lymphoma; rituximab; autologous transplantation;

D O I：

10.1038/sj.bmt.1704467

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.

引用

页码：921 / 923

页数：3

共 50 条

[21] 90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
Ria, Roberto
Musto, Pellegrino
Reale, Antonia
Guariglia, Roberto
Iodice, Giuseppe
Dammacco, Franco
Vacca, Angelo
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) : 891 - 895
[22] Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
Flinn, IW
O'Donnell, PV
Goodrich, A
Vogelsang, G
Abrams, R
Noga, S
Marcellus, D
Borowitz, M
Jones, R
Ambinder, RF
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 628 - 632
[23] Disseminated Cryptococcosis in a Non-Hodgkin's Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review
Hirai, Yuji
Ainoda, Yusuke
Shoji, Takayo
Fujita, Takahiro
Yoshinaga, Kentaro
Shiseki, Masayuki
Mori, Naoki
Teramura, Masanao
Totsuka, Kyoichi
Motoji, Toshiko
MYCOPATHOLOGIA, 2011, 172 (03) : 227 - 232
[24] Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma
Kriegsmann, Katharina
Rieger, Michael
Schwarzbich, Mark-Alexander
Sitter, Soeren
Kriegsmann, Mark
Bruckner, Thomas
Hensel, Manfred
Ho, Anthony Dick
Witzens-Harig, Mathias
Wuchter, Patrick
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 12 - 20
[25] Disseminated Cryptococcosis in a Non-Hodgkin’s Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review
Yuji Hirai
Yusuke Ainoda
Takayo Shoji
Takahiro Fujita
Kentaro Yoshinaga
Masayuki Shiseki
Naoki Mori
Masanao Teramura
Kyoichi Totsuka
Toshiko Motoji
Mycopathologia, 2011, 172 : 227 - 232
[26] Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL)
BenYosef, R
Braverman, I
Saah, D
Nagler, R
Shohat, S
Or, R
Nagler, A
BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 1017 - 1019
[27] STEM CELL TRANSPLANTATION FOR NON-HODGKIN'S LYMPHOMA (NHL)
De Souza, Carmino
LEUKEMIA RESEARCH, 2017, 61 : S11 - S12
[28] Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma
Arai, Yasuyuki
Yamashita, Kouhei
Mizugishi, Kiyomi
Nishikori, Momoko
Hishizawa, Masakatsu
Kondo, Tadakazu
Kitano, Toshiyuki
Kawabata, Hiroshi
Kadowaki, Norimitsu
Takaori-Kondo, Akifumi
Hematology, 2015, 20 (04) : 196 - 202
[29] Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma
Michal Sieniawski
Oliver Staak
Jan-Peter Glossmann
Thorsten Reineke
Helena Scheuß
Volker Diehl
Andreas Engert
Andreas Josting
Annals of Hematology, 2007, 86 : 107 - 115
[30] Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
Kato, Harumi
Yamamoto, Kazuhito
Taji, Hirofumi
Oki, Yasuhiro
Chihara, Dai
Seto, Masao
Kagami, Yoshitoyo
Morishima, Yasuo
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 483 - 489

← 1 2 3 4 5 →